4Alings AM,Fliers E,de Herder WW,et al.A thyrotropin-secreting pituitary adenoma as a cause of thyrotoxic periodic paralysis[J].J Endocrinol Invest,1998,21(10):703-706.
9Da Silva MRD,Cerutti JM,Arnaldi LAT,et al.A mutation in the KCNE3 potassium channel gene is associated with susceptibility to thyrotoxic hypokalaemic periodic paralysis[J].J Clin Endocrinol metab,2002,87:4881-4884.
二级参考文献7
1Caron P,Arlot S,Bauters C,et al.Efficacy of the long-acting octreotide formulation ( octreotide-LAR ) in patients with thyrotropin-secreting pituitary adenomas[].The Journal of Clinical Endocrinology.2001
2Lundin P,Pedersen F.Volume of pituitary macroadenomas:assessment by MRI[].Journal of Computational Finance.1992
3Socin HV,Chanson P,Delemer B,et al.The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients[].European Journal of Endocrinology.2003
